InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,158.62
(
0.60%
)
US TECH 100
17,540.00
(
0.69%
)
Dow Jones
38,753.37
(
0.20%
)
Brent Oil
83.12
(
-0.01%
)
Bitcoin
63,417.22
(
-0.91%
)
Post# of 458384
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 65
Posts 7224
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: ExtremelyBullishZig post# 106012

Tuesday, 05/23/2017 9:39:18 PM

Tuesday, May 23, 2017 9:39:18 PM

Post# of 458384
If rare diseases are the fastest way to approval then why didn't we start a trial for a rare disease 18 months ago? Based on the timetable, we would have been approved over 5 months ago and then prescribed for off-label for AD related insomnia.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!